Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic and orthopedic markets. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic or orthopedic industry newsletters.
Recently Added
Safer and More Effective Glaucoma Surgical Options Will Drive Surgery Device Treatment Penetration Over Next Five Years
Expanding use of surgical devices in patients with all stages of glaucoma will increase the role of surgery in the glaucoma treatment paradigm over the next five years. There are four FDA-approved ...
AAO, ASCRS Ask Congress to Prevent 6 Percent Reduction in Ophthalmologists’ Fees
The American Academy of Ophthalmology (AAO) and American Society of Cataract and Refractive Surgery (ASCRS) have asked Congress to prevent the latest proposed cuts in Medicare reimbursement to opht...
US FDA Accepts Clearside’s IND Application for Axitinib Suprachoroidal Injection
Clearside Biomedical announced Aug. 10 that the US FDA had accepted its investigational new drug (IND) application for CLS-AX (axitinib injectable suspension) for wet age-related macular degenerati...
Avellino Hits Milestone of 1 Million Genetic Tests
Avellino announced Aug. 13 that the company has topped 1 million genetic and molecular diagnostic tests. The Menlo Park, California, company said the milestone includes more than 821 thousand AvaGe...
Ocugen Gets Fourth Orphan Drug Designation for OCU400 Gene Therapy Candidate
Ocugen, of Malvern, Pennsylvania, announced Aug. 10 that the US FDA had granted its fourth orphan drug designation for OCU400, this one for the treatment of PDE6B gene mutation-associated retinal d...
Eyenovia, Arctic Vision Team Up to Commercialize MicroPine, MicroLine in Greater China, South Korea
Eyenovia, of New York, and China’s Arctic Vision announced Aug. 11 that they had entered into an exclusive license agreement for Arctic Vision to develop and commercialize MicroPine for progressive...
Amydis Gets New Michael J. Fox Foundation Grant to Diagnose Parkinson’s Through Retina
Amydis, of San Diego, announced Aug. 11 that it had received a new grant from the Michael J. Fox Foundation for Parkinson’s Research for the company’s pioneering retinal tracer program for alpha-sy...
Omeros Expects to Net $297.4 Million in Two Public Offerings
Omeros, of Seattle, announced Aug. 12 that it had priced concurrent underwritten public offerings of 6.9 million shares of its common stock at $14.50 per share, for proceeds of approximately $100 m...
TearClear Raises $22 Million in Series B Funding
TearClear, of Boston, announced Aug. 11 that it had raised $22 million in a Series B funding round. The company said the investment will be used to advance multiple clinical programs, with two lead...
OrthoPAC Backs Three Surgeons Running for Congress, One Remains
The Orthopaedic Political Action Committee (OrthoPAC) of the American Association of Orthopaedic Surgeons (AAOS) endorsed three candidates for the US Congressional election in November. This is the...
LaunchPad Medical Rebrands As RevBio
Massachusetts-based LaunchPad Medical rebranded as RevBio, the company announced Aug. 4. RevBio’s predominant offering is Tetranite bone adhesive biomaterial. Tetranite is used in dental and orthop...
NEO Pedicle Screw System Saves Time and Money in Study
Neo Medical announced July 29 that a study of its NEO Pedicle Screw System was recently published in Interdisciplinary Neurosurgery. The study compared the average surgical time and overall procedu...
Past News Stories
OIC Launches One Procedure, One Price Initiative
The Orthopaedic Implant Company (OIC) announced July 29 that it has launched its One Procedure, One Price initiative, which is designed to ensure a standard cost of care for orthopedic procedures. ...
Bausch Health to Spin Out Bausch + Lomb to Separate Publicly Traded Company
.jpg)
Canada-headquartered Bausch Health Companies announced Aug. 6 that it plans to spin off Bausch + Lomb into a separate publicly traded company. The new entity will be called Bausch + Lomb—NewCo and ...
Q2-2020 Earnings: Ocular Therapeutix, Aerie, Bausch + Lomb, LENSAR, Six More
Ocular Therapeutix reported Aug. 7 that its Q2-2020 net product revenue was $1.6 million, with $1.4 million for Dextenza and $0.2 million for ReSure Sealant. The company had revenue of $650 thousan...
EyePoint, ImprimisRx Join Forces to Promote Dexycu in the US
EyePoint Pharmaceuticals and ImprimisRx announced Aug. 4 that they had formed a commercial alliance for the joint promotion in the US of Dexycu (dexamethasone intraocular suspension) 9% for the tre...
Surgeon’s 15-Second UVC Treatment for Corneal Infections Wins 2020 Winning Pitch Challenge
Sunil Shah, MD, of the UK, won the 2020 Winning Pitch Challenge with a UVC device candidate he co-invented to treat corneal infections. He represented Photon Therapeutics and its team of five in th...
Lumibird Acquires Scandinavian Distributor EssMed
French laser company Lumibird announced Aug. 3 that it had acquired EssMed, one of its distribution companies. EssMed operates in Sweden, Finland, and Norway, with revenue of around €2 million (US ...
Eyenuk Gains FDA Clearance for EyeArt Autonomous AI for DR Screening
Eyenuk announced Aug. 5 that it had received 510(k) clearance from the US FDA to market its EyeArt autonomous AI system for diabetic retinopathy (DR). Eyenuk, of Woodland Hills, California, says it...
Iacta, Led by Former Allergan Execs, to Collaborate with Zhaoke on Two Eye Candidates
Irvine, California-based Iacta Pharmaceuticals will co-develop two of its ophthalmic drug candidates with Hong Kong’s Zhaoke Ophthalmology Pharmaceutical Limited, a subsidiary of Lee's Pharmace...
Eurazeo China Acceleration Fund Invests €80 Million in DORC
Paris-based Eurazeo announced July 27 that its Eurazeo China Acceleration Fund made an €80 million investment in Dutch Ophthalmic Research Center (DORC) as its first backing. DORC is a portfolio co...
Retina-AI Health Raises $5.2 Million in Series A Financing for its for AI Detection of DR
Retina-AI Health, of Houston, announced Aug. 6 that it had raised $5.2 million in a Series A financing for its AI screening of diabetic retinopathy. The company said the capital was raised from pri...
iOR Partners Adds Tom Frinzi to Board
iOR Partners, the Kansas City company pioneering office-based surgery in ophthalmology, announced July 29 that industry veteran Tom Frinzi had joined its board of directors. Daniel Durrie, MD, iOR ...
Oxurion Appoints Grace Chang, MD, PhD, as Chief Medical Officer
Belgian company Oxurionannounced Aug. 3 that it had appointed Grace Chang, MD, PhD, as the company’s chief medical officer. Chang is a practicing vitreoretinal surgeon with deep expertise in ophtha...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.